Summaries for Spina Bifida

Sources:
30NIH Rare Diseases, 23MedlinePlus, 2CDC, 31NINDS, 17Genetics Home Reference, 44Wikipedia, 33OMIM, 22MalaCards
See all sources

Export this MalaCard
NINDS: Spina bifida (SB) is a neural tube defect (a disorder involving incomplete development of the brain, spinal cord, and/or their protective coverings) caused by the failure of the fetus's spine to close properly during the first month of pregnancy. Infants born with SB sometimes have an open lesion on their spine where significant damage to the nerves and spinal cord has occurred. Although the spinal opening can be surgically repaired shortly after birth, the nerve damage is permanent, resulting in varying degrees of paralysis of the lower limbs. Even when there is no lesion present there may be improperly formed or missing vertebrae and accompanying nerve damage. In addition to physical and mobility difficulties, most individuals have some form of learning disability. The types of SB are: myelomeningocele, the severest form, in which the spinal cord and its protective covering (the meninges) protrude from an opening in the spine; meningocele in which the spinal cord develops normally but the meninges and spinal fluid) protrude from a spinal opening; closed neural tube defects, which consist of a group of defects in which development of the spinal cord is affected by malformations of the fat, bone, or meninges; and and occulta, the mildest form, in which one or more vertebrae are malformed and covered by a layer of skin. SB may also cause bowel and bladder complications, and many children with SB have hydrocephalus (excessive accumulation of cerebrospinal fluid in the brain).31

MalaCards: Spina Bifida, also known as rachischisis, is related to myelomeningocele and neural tube defect. An important gene associated with Spina Bifida is AFP (alpha-fetoprotein), and among its related pathways are Methylation and Thiopurine Pathway, Pharmacokinetics/Pharmacodynamics. The compounds folic acid and 5-methyltetrahydrofolate have been mentioned in the context of this disorder. Affiliated tissues include brain, spinal cord and heart, and related mouse phenotypes are respiratory system and hearing/vestibular/ear.

NIH Rare Diseases: Spina bifida is a type of neural tube defect in which the bones of the spinal column do not close completely around the developing nerves of the spinal cord during the development of the embryo. As a result, part of the spinal cord may stick out through an opening in the spine, leading to permanent nerve damage. Children born with spina bifida often have a fluid-filled sac on their back covered by skin. If the sac contains part of the spinal cord and its protective covering, it is known as a myelomeningocele; if it does not, it is known as a meningocele. The signs and symptoms range from mild to severe (depending on the location and extent of spinal cord involvement) and can include a loss of feeling below the level of the opening; weakness or paralysis of the feet or legs; problems with bladder and bowel control; hydrocephalus; and learning problems. With surgery and other forms of treatment, many people with spina bifida live into adulthood. There is also a milder form of the condition called spina bifida occulta.30

MedlinePlus: Spina bifida is the most common disabling birth defect in the united states. it is a type of neural tube defect, which is a problem with the spinal cord or its coverings. it happens if the fetal spinal column doesn't close completely during the first month of pregnancy. there is usually nerve damage that causes at least some paralysis of the legs. many people with spina bifida will need assistive devices such as braces, crutches or wheelchairs. they may have learning difficulties, urinary and bowel problems or hydrocephalus, a buildup of fluid in the brain. there is no cure. treatments focus on the complications, and can include surgery, medicine and physiotherapy. taking folic acid can reduce the risk of having a baby with spina bifida. it's in most multivitamins. women who could become pregnant should take it daily. nih: national institute of neurological disorders and stroke23

CDC: Spina bifida is a major birth defect of a person’s spine.  With good quality medical care people with spina bifida can reach their full potential. If you have spina bifida, or know someone who does, it’s important to get the facts so that you can make the best possible health care choices. 2

Genetics Home Reference: Spina bifida is a condition in which the bones of the spinal column do not close completely around the developing nerves of the spinal cord. As a result, part of the spinal cord may stick out through an opening in the spine, leading to permanent nerve damage. Spina bifida results when a structure called the neural tube fails to close completely during the first few weeks of embryonic development. The neural tube is a layer of cells that ultimately develops into the brain and spinal cord. Because spina bifida is caused by abnormalities of the neural tube, it is classified as a neural tube defect (NTD).17

Wikipedia: Spina bifida (Latin: \"split spine\") is a developmental congenital disorder caused by the incomplete...44 more...

OMIM: 182940

Aliases & Descriptions for Spina Bifida

Sources:
2CDC, 30NIH Rare Diseases, 6Disease Ontology, 7diseasecard, 17Genetics Home Reference, 31NINDS, 8DISEASES, 33OMIM, 32Novoseek , 23MedlinePlus
See all sources
spina bifida 6 7 30 17 31 8 33 32 23
rachischisis 30 17
cleft spine 30 17
open spine 30 17
spinal dysraphism 30

Related Diseases for Spina Bifida

Sources:
13GeneCards, 14GeneDecks
See all sources

Diseases related to spina bifida by text searches and GeneDecks gene sharing:

(show top 50)    (show all 314)
idRelated DiseaseScoreTop Affiliating Genes
1myelomeningocele34.2VANGL1, PAX3, MTRR, MTHFR, MTR, MTHFD1
2neural tube defect33.9NAT1, VANGL1, VANGL2, ZIC1, ZIC2, PAX3
3orofacial cleft32.1PCYT1A, NAT1, NAT2, BHMT, BHMT2, CHKA
4anencephaly31.3VANGL1, BCHE, MTRR, MTHFR, MTR, MTHFD1
5congenital heart defect30.7RFC1, BHMT, CITED2, MTRR, MTHFR, MTR
6hernia30.2PAX3, CGB7, CCL2, IGHE, ALDH1A2, CYP26A1
7congenital diaphragmatic hernia30.1PAX3, CGB7, ALDH1A2, CYP26A1, NOS2, NOS3
8hydrocephalus29.7MTHFR, L1CAM, APOB, APOE, ALDH1L1, NOS1
9vascular disease28.7BHMT, MTRR, MTHFR, MTR, APOB, APOE
10homocysteine27.9RFC1, PCMT1, NAT1, NAT2, BHMT, BHMT2
11schizophrenia23.7PCMT1, NAT1, NAT2, ZIC2, BCHE, LEPR
12homocysteinemia14.1MTRR, MTHFR, MTR, CBS, SLC19A1
13stickler syndrome14.1RFC1, PAX9, MTRR, MTHFR, MTR, MTHFD1
14glycine n-methyltransferase deficiency14.0MTHFR, MAT2A, MAT1A, GNMT, CBS
15homocysteine plasma level14.0RFC1, MTRR, MTHFR, MTR, NNMT, TCN2
16hypermethioninemia14.0MAT2A, MAT1A, GNMT, CBS, CTH, ACHE
17phenylketonuria13.9MTRR, MTHFR, MTR, FOLH1, SPR, ACHE
18vitamin b12 deficiency13.9MTHFR, MTR, TCN2
19placental abruption13.9RFC1, BHMT, MTRR, MTHFR, MTHFD1, NOS3
20homocystinuria13.9BHMT, MTRR, MTHFR, MTR, MAT1A, CBS
21cleft lip13.8RFC1, NAT1, ZIC2, BHMT, BHMT2, PAX9
22thiamine-responsive megaloblastic anemia syndrome13.8MTRR, MTHFR, MTR, CUBN, TCN2
23birth defects13.8MTRR, MTHFR, MTR, MTHFD1, CGB5, CUBN
24cleft palate13.8RFC1, NAT1, NAT2, BHMT, BHMT2, PAX9
25multiple chemical sensitivity13.7NAT1, NAT2, MTHFR, PON1
26pediatric osteosarcoma13.7RFC1, MTHFR, MTR, FOLR1, PDGFRA, SHMT1
27nonseminomatous germ cell tumor13.7CGB5, CGB7, AFP
28methylmalonic aciduria and homocystinuria13.7MTR, CBS, TCN2
29hirschsprung's disease13.7PAX3, BCHE, L1CAM, NOS1, ACHE
30pancytopenia13.7MGMT, CBS, TCN2, DHFR, AFP
31central nervous system lymphoma13.7MTHFR, MTR, MGMT, CCL2, PDGFRA, ABCC2
32folic acid deficiency anemia13.6MTHFR, MTR, FPGS, FOLR1, CBS, TYMS
33adult acute lymphocytic leukemia13.6MTHFR, MTR, SHMT1, TYMS
34venous thrombosis13.5MTHFR, MTR, APOB, CBS, AHCY
35bladder cancer susceptibility13.5NAT2, MTHFR, MTR, XRCC1, APEX1, ERCC2
36childhood leukemia13.5MTHFR, MTR, XRCC1, FPGS, SHMT1, TYMS
37gastroschisis13.5MTHFR, NOS1, NOS3, ACHE, CST3, AFP
38colorectal cancer13.5NAT1, NAT2, MTHFR, MTR, APOE
39cardia cancer13.5MTRR, MTHFR, XRCC1, TYMS
40tetrahydrobiopterin deficiency13.4SPR, NOS1, NOS3, DHFR
41recessive developmental delay, small stature, microcephaly and brain calcifications13.4MTR, ERCC2, PTCH1, SHH, SLC2A1, GAMT
42pediatric cns embryonal cell carcinoma13.4CGB5, CGB7, CYP26A1, PDGFRA, TFAP2A, EP300
43acute lymphoblastic leukemia, childhood13.4NAT1, LEPR, MTHFR, MTHFD1, XRCC1, FPGS
44hemifacial spasm13.3MTHFR, NOS3, TYMS
45cognitive disease13.3BCHE, APOE, CREBBP, ACHE
46deep vein thrombosis13.3MTRR, MTHFR, MTR, CBS, NOS3
47rectal cloacogenic carcinoma13.3NAT1, NAT2, CGB5, CGB7, FOLH1, PTCH1
48neuroendocrine carcinoma13.3L1CAM, FOLH1, IGHE, PDGFRA, SHH, OGG1
49intellectual disability13.2MTRR, MTR, L1CAM, CBS, CREBBP, NOS1
50sinusitis13.2VANGL1, MTHFR, CGB7, CCL2, IGHE, CBS

Graphical network of the top 20 diseases related to spina bifida:



Graphical network of diseases related to spina bifida

Clinical Features for Spina Bifida

Sources:
33OMIM
See all sources
Clinical features from OMIM: 182940

Drugs & Therapeutics for Spina Bifida

Sources:
4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials, 43UMLS, 28NDF-RT
See all sources

Approved drugs:

Search CenterWatch for spina bifida

Drug clinical trials:

Search ClinicalTrials for spina bifida

Search NIH Clinical Center for spina bifida

Search CenterWatch for spina bifida

Genetic Tests for Spina Bifida

Anatomical Context for Spina Bifida

Sources:
22MalaCards
See all sources

MalaCards organs/tissues related to spina bifida:

22
Brain, Spinal cord, Heart, Skin, T cells, Endothelial, Fetal brain

Phenotypes for genes affiliated with Spina Bifida

Sources:
25MGI
See all sources

MGI Mouse Phenotypes related to spina bifida:

25 (show all 28)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1respiratory system phenotypeMP:0005388INFUNCX, PAX3, PAX9, PAX7, VANGL2, VANGL1
2hearing/vestibular/ear phenotypeMP:0005377INFALDH1A2, ALX1, SHH, ACHE, TFAP2A, PEMT
3limbs/digits/tail phenotypeMP:0005371INFTFAP2A, BRCA1, VANGL1, VANGL2, ZIC2, PAX1
4embryogenesis phenotypeMP:0005380INFSLC19A1, PES1, PRMT1, PRICKLE1, CUBN, CREBBP
5mortality/agingMP:0010768INFCYP26A1, CYP26B1, CYP26C1, CUBN, SPR, CTH
6vision/eye phenotypeMP:0005391INFPTCH1, ERCC2, CBS, ALX1, ALDH1A2, CCL2
7hematopoietic system phenotypeMP:00053979.3ALAS2, GNMT, TRDMT1, PDGFRA, HK1, DNMT1
8no phenotypic analysisMP:00030129.2CYP26A1, CYP26B1, ACHE, DNMT1, PRMT2, PRMT1
9liver/biliary system phenotypeMP:00053708.5CTH, NOS3, SHMT1, SHROOM3, HK1, SLC19A1
10pigmentation phenotypeMP:00011868.0DNMT1, TFAP2A, PDGFRA, PTCH1, ERCC2, CCL2
11normal phenotypeMP:00028737.9CYP26A1, PTCH1, TRDMT1, ALX1, ALDH1A2, ICMT
12renal/urinary system phenotypeMP:00053677.4NOS3, NOS2, NOS1, CTH, CUBN, PDGFRA
13adipose tissue phenotypeMP:00053757.2PRKCA, ACHE, NOS3, NOS2, NOS1, CREBBP
14muscle phenotypeMP:00053696.6NOS3, NOS2, NOS1, CREBBP, CTH, PDGFRA
15immune system phenotypeMP:00053875.8NOS2, NOS1, CREBBP, PTCH1, TRDMT1, ERCC2
16cellular phenotypeMP:00053844.8PDGFRA, NOS3, NOS2, NOS1, CREBBP, CTH
17cardiovascular system phenotypeMP:00053854.5NOS2, NOS1, CREBBP, CTH, CUBN, CYP26A1
18homeostasis/metabolism phenotypeMP:00053762.7PCYT1A, DNMT3A, DNMT1, PRKCB, PRMT2, PRKCA
19endocrine/exocrine gland phenotypeMP:0005379INFCYP26B1, SLC19A1, AFP, GAMT, ALDH1A2, CITED2
20behavior/neurological phenotypeMP:0005386INFNOS1, CREBBP, CTH, SPR, PTCH1, ERCC2
21nervous system phenotypeMP:0003631INFACTL6B, PAX3, UNCX, , CITED2, MTHFR
22digestive/alimentary phenotypeMP:0005381INFNOS3, NOS2, NOS1, CREBBP, CYP26A1, PDGFRA
23reproductive system phenotypeMP:0005389INFNOS2, CYP26B1, CYP26A1, PTCH1, ERCC2, PDGFRA
24tumorigenesisMP:0002006INFGNMT, CCL2, APEX1, GRHL3, MGMT, FOLR1
25craniofacial phenotypeMP:0005382INF, CECR2, T, L1CAM, CITED2, PAX3
26skeleton phenotypeMP:0005390INFTFAP2A, SHROOM3, PCMT1, MTHFR, LEPR, UNCX
27integument phenotypeMP:0010771INFCBS, ERCC2, PTCH1, CREBBP, PDGFRA, SHH
28growth/size phenotypeMP:0005378INFPEMT, EP300, GAMT, SLC19A1, SLC2A1, FOLR1

Publications for genes affiliated with Spina Bifida

Sources:
35PubMed
See all sources

Articles related to spina bifida:

(show top 50)    (show all 86)
idTitleAuthorsYearAffiliating Genes
1677C>T and 1298A>C polymorphisms of methylenete trahydropholate reductase gene and biochemical parameters in Turkish population with spina bifida occulta. (20066615)Eser B.... Solak M.2010MTHFR
2Paraoxonase 1 polymorphisms and haplotypes and the ri sk for having offspring affected with spina bifida in Southeast Mexico. (21031563)Gonzalez-Herrera L.... Quintanilla-Vega B.2010PON1
3Prevalance of latex sensitization and associated risk factors in Turkish children with spina bifida. (20162419)Ozkaya E.... Samanci N.2010IGHE
4Genetic association study of putative functional sing le nucleotide polymorphisms of genes in folate metabolism and spina bifida. (19683694)Martinez C.A.... Au K.S.2009TYMS, CBS, AHCY
5An association study of 45 folate-related genes in spina bifida: Involvement of cubilin (CUBN) and tRNA aspartic acid methyltransferase 1 (TRDMT1). (19161160)Franke B.... Blom H.J.2009TYMS, CBS, NOS3
6Nicotinamide N-methyl transferase (NNMT) gene polymorphisms and risk for spina bifida. (18553462)Lu W.... Finnell R.H.2008NNMT
7Variation and expression of dihydrofolate reductase (DHFR) in relation to spina bifida. (17336564)van der Linden I.J.... Blom H.J.2007DHFR, MSH3
8Association between CFL1 gene polymorphisms and spina bifida risk in a California population. (17352815)Zhu H.... Finnell R.H.2007CFL1
9The methylenetetrahydrofolate dehydrogenase (MTHFD1) 1958G>A variant is not associated with spina bifida risk in the Dutch population. (17894836)van der Linden I.J.... Blom H.J.2007MTHFD1
10Screening for novel PAX3 polymorphisms and risks of spina bifida. (17149730)Lu W.... Finnell R.H.2007PAX3
11Phosphatidylethanolamine N-methyltransferase (PEMT) gene polymorphisms and risk of spina bifida. (16523512)Zhang J.... Finnell R.H.2006PEMT
12Evidence for a functional genetic polymorphism of the human retinoic acid-metabolizing enzyme CYP26A1, an enzyme that may be involved in spina bifida. (16933217)Rat E.... Broly F.2006CYP26A1, CYP26B1, CYP26C1
13CHKA and PCYT1A gene polymorphisms, choline intake and spina bifida risk in a California population. (17184542)Enaw J.O.... Finnell R.H.2006PCYT1A, CHKA
14Loss of function polymorphisms in NAT1 protect against spina bifida. (16680433)Jensen L.E.... Whitehead A.S.2006NAT1
15Promotor genotype of the platelet-derived growth factor receptor-alpha gene shows population stratification but not association with spina bifida meningomyelocele. (16283668)Au K.S.... King T.M.2005PDGFRA
16Evidence that the risk of spina bifida is influenced by genetic variation at the NOS3 locus. (15039923)Brown K.S.... Mitchell L.E.2004NOS3
17Spina bifida and genetic factors related to myo-inositol, glucose, and zinc. (15172003)Groenen P.M.W.... Steegers-Theunissen R.P.M.2004SLC5A11
18New 19 bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR): a risk factor for spina bifida acting in mothers during pregnancy? (14735580)Johnson W.G.... Buyske S.2004DHFR, MTHFR
19A common ABCC2 promoter polymorphism is not a determinant of the risk of spina bifida. (15211708)Jensen L.E.... Mitchell L.E.2004ABCC2
20Associations between polymorphisms within the thymidylate synthase gene and spina bifida. (14745930)Volcik K.A.... Finnell R.H.2003TYMS
21Risk factors for neural tube defects: associations between uncoupling protein 2 polymorphisms and spina bifida. (12797456)Volcik K.A.... Finnell R.H.2003UCP2
22Measuring glomerular filtration rate with cystatin C and beta-trace protein in children with spina bifida. (12771788)Pham-Huy A.... Filler G.2003CST3
23Evaluation of infant methylenetetrahydrofolate reductase genotype, maternal vitamin use, and risk of high versus low level spina bifida defects. (12797455)Volcik K.A.... Finnell R.H.2003MTHFR
24Methylenetetrahydrofolate reductase (MTHFR): incidence of mutations C677T and A1298C in Brazilian population and its correlation with plasma homocysteine levels in spina bifida. (12707953)Perez A.B.... Brunoni D.2003MTHFR
25Polymorphisms of the 5,10-methylenetetrahydrofolate and the methionine synthase reductase genes as independent risk factors for spina bifida. (12590188)Pietrzyk J.J.... Twardowska M.2003MTHFR, MTRR
26Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida. (11857541)Shaw G.M.... Finnell R.H.2002RFC1, SLC19A1
27Spina bifida and folate-related genes: a study of gene-gene interactions. (12180146)de Franchis R.... Mastroiacovo P.2002CBS, MTHFR
28Orofacial clefts and spina bifida: N-acetyltransferase phenotype, maternal smoking, and medication use. (12397635)van Rooij I.A.... Steegers-Theunissen R.P.2002NAT2
29Maternal genetic effects, exerted by genes involved in homocysteine remethylation, influence the risk of spina bifida. (12375236)Doolin M.-T.... Mitchell L.E.2002MTR, MTRR
30Hev b 7 is a Hevea brasiliensis protein associated with latex allergy in children with spina bifida. (11590391)Wagner B.... Breiteneder H.2001IGHE
31Vascular diseases, spina bifida and schizophrenia in a single family associated with the heterozygote mutation of the heat-sensitive variant of methylenetetrahydrofolate reductase (11481907)HorvA!th A.... KosztolA!nyi G.2001MTHFR
32Cloning, expression, and characterization of recombinant Hev b 3, a Hevea brasiliensis protein associated with latex allergy in patients with spina bifida. (10550757)Wagner B.... Breiteneder H.1999IGHE
33A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. (10444342)Wilson A.... Rozen R.1999MTHFR, MTRR
34Re: 'Maternal vitamin use, genetic variation of infant methylenetetrahydrofolate reductase, and risk for spina bifida'. (10430239)Botto L.D.... Mulinare J.1999MTHFR
35Infant methionine synthase variants and risk for spina bifida. (9950377)Shaw G.M.... Rozen R.1999MTR
36Altered regulation of platelet-derived growth factor receptor-alpha gene-transcription in vitro by spina bifida-associated mutant Pax1 proteins. (9826722)Joosten P.H.... Mariman E.C.1998PDGFRA
37Lack of association between mutations in the folate receptor-alpha gene and spina bifida. (9545095)Barber R.C.... Finnell R.H.1998FOLR1
38The C677T mutation of the 5,10-methylenetetrahydrofolate reductase gene is a moderate risk factor for spina bifida in Italy. (9863598)de Franchis R.... Mastroiacovo P.1998MTHFR
39Latex provocation tests in patients with spina bifida: who is at risk of becoming symptomatic? (9802377)Niggemann B.... Wahn U.1998IGHE
40Impaired regeneration of monoglutamyl tetrahydrofolate leads to cellular folate depletion in mothers affected by a spina bifida pregnancy. (9787091)Lucock M.D.... Levene M.I.1998MTHFR
41Maternal vitamin use, genetic variation of infant methylenetetrahydrofolate reductase, and risk for spina bifida. (9663401)Shaw G.M.... Lammer E.J.1998MTHFR
42Evaluation of the MTHFR C677T allele and the MTHFR gene locus in a German spina bifida population. (9667406)Koch M.C.... Ermert A.1998MTHFR
43On the allergenicity of Hev b 1 among health care workers and patients with spina bifida allergic to natural rubber latex. (9389300)Chen Z.... Baur X.1997IGHE
44Altered folate and vitamin B12 metabolism in families with spina bifida offspring. (9327028)van der Put N.M.... Blom H.J.1997MTR, MTHFD1, MTHFR
45Relevance to spina bifida of mutated methylenetetrahydrofolate reductase. (8569408)Wilcken D.E.... Wang X.L.1996MTHFR
46X-linked hydrocephalus masquerading as spina bifida a nd destructive porencephaly in successive generations in one family. (8641541)Brewer C.M.... Tolmie J.L.1996L1CAM
47PAX genes and human neural tube defects: an amino acid substitution in PAX1 in a patient with spina bifida. (8863157)Hol F.A.... Mariman E.C.M.1996PAX3, PAX7, PAX9
48A frameshift mutation in the gene for PAX3 in a girl with spina bifida and mild signs of Waardenburg syndrome. (7897628)Hol F.A.... Mariman E.C.1995PAX3
49Latex allergy: frequent occurrence of IgE antibodies to a cluster of 11 latex proteins in patients with spina bifida and histories of anaphylaxis. (8195677)Alenius H.... Fink J.1994IGHE
50Prenatal diagnosis of spina bifida aperta after first-trimester valproate exposure. (1283633)Omtzigt J.G.... Lindhout D.1992AFP

Expression for genes affiliated with Spina Bifida

Sources:
1BioGPS
See all sources
Expression patterns in normal tissues for genes affiliated with Spina Bifida

Pathways for genes affiliated with Spina Bifida

Sources:
38Reactome, 34PharmGKB, 20KEGG, 10EMD Millipore, 41Thomson Reuters, 36QIAGEN
See all sources

Pathways related to spina bifida according to GeneDecks:

(show all 23)
idPathwayScoreTop Affiliating Genes
1Methylation3810.7AHCY, NNMT, MAT2B, MAT1A, MAT2A, MTR
2Thiopurine Pathway, Pharmacokinetics/Pharmacodynamics3410.6MTRR, MTHFR, MTR, MTHFD1, MTHFS, CBS
3Folate biosynthesis2010.6GGH, DHFR, SPR, FPGS
4Antimetabolite Pathway - Folate Cycle, Pharmacodynamics3410.5GART, MTRR, MTHFR, MTR, MTHFD1, MTHFS
5Glycine, serine and threonine metabolism2010.5GAMT, SHMT1, CTH, CBS, GNMT, ALAS2
6One carbon pool by folate2010.4MTHFS, MTHFD2, ATIC, FTCD, AMT, ALDH1L1
7Metabolism of amino acids and derivatives3810.4GAMT, SHMT1, AMD1, FTCD, CGB7, CGB5
8Methionine metabolism1010.4MTR, MAT2A, MAT1A, CBS, CTH, AHCY
9Methionine metabolism4110.3MAT2A, MAT1A, CTH, DNMT3A, DNMT1
10Methotrexate Pathway (Cancer Cell), Pharmacodynamics3410.3ATIC, FPGS, CBS, SHMT1, ABCC2, TYMS
11Busulfan Pathway, Pharmacodynamics3410.2CTH, APEX1, MGMT, NAT2, NAT1
12Cysteine and methionine metabolism2010.2CBS, TRDMT1, CTH, AHCY, DNMT3A, DNMT1
13Fluoropyrimidine Pathway, Pharmacodynamics3410.2GGH, DHFR, TYMS, ERCC2, FPGS, XRCC3
14Transcription_Ligand-dependent activation of the ESR1/SP pathway419.7EP300, TYMS, ACTL6B, CREBBP, CARM1
15Selected targets of Oct-3/4109.6DNMT1, DNMT3A, PDGFRA, T, CGB7, BRCA1
16Transcription Ligand-dependent activation of the ESR1/SP pathway109.6EP300, TYMS, ACTL6B, CREBBP, CARM1
17Vitamin digestion and absorption209.5SLC19A1, TCN2, CUBN, APOB, FOLH1
18HIF1Alpha Pathway369.5EP300, SLC2A1, TCP1, NOS3, CREBBP, APEX1
19Arginine and proline metabolism209.5NOS3, NOS2, NOS1, AMD1, GAMT
20Doxorubicin Pathway, Pharmacokinetics349.3ABCC2, NOS3, NOS2, NOS1
21DNA Repair Mechanisms369.0OGG1, ERCC2, APEX1, MGMT, MSH3, XRCC1
22Metabolic pathways207.8PCYT1A, MAT2B, AMD1, AMT, ALAS2, ALDH1A2
23Pathways in cancer207.8EP300, SLC2A1, PRKCA, PRKCB, SHH, PDGFRA

Compounds for genes affiliated with Spina Bifida

Sources:
34PharmGKB, 9DrugBank, 18HMDB, 32Novoseek , 42Tocris Bioscience
See all sources

Compounds related to spina bifida according to GeneDecks:

(show top 50)    (show all 208)
idCompoundScoreTop Affiliating Genes
1folic acid34 9 18 9 13.9GGH, SLC19A1, DHFR, GNMT, FOLR3, FOLR2
25-methyltetrahydrofolate32 9 9 12.9SLC19A1, ABCC2, CBS, FOLR2, FOLR1, MTHFS
310-formyltetrahydrofolate32 10.7MTHFD1, ATIC, ALDH1L1, SLC19A1, MTR, MTHFR
4L-Methionine9 18 9 12.7MAT1A, BHMT, BHMT2, MTRR, MTR, MAT2A
5b vitamins32 10.6SHMT1, MTRR, MTHFR, MTR, CBS, TYMS
6tetrahydrofolate32 10.6MTRR, MTR, FPGS, ALDH1L1, SHMT1, TYMS
7lometrexol32 10.5SLC19A1, TYMS, FOLR1, FPGS, ATIC, GART
8Tetrahydrofolic acid9 18 9 12.4MTHFR, MTR, MTHFD1, GGH, GART, DHFR
9glycinamide ribonucleotide32 9 9 12.4ATIC, FPGS, TYMS, DHFR, GART, GGH
10cobalamin32 18 11.3CBS, MTHFD1, CUBN, MTRR, TCN2, MTR
11leucovorin32 34 9 9 13.3DHFR, FTCD, SLC19A1, MTHFS, CGB5, FPGS
12vitamin b632 10.3SHMT1, CST3, TCN2, TYMS, CTH, CBS
13s-adenosylhomocysteine32 18 11.2NNMT, TRDMT1, CARM1, CBS, GNMT, ICMT
14cystathionine32 10.2MTHFD1, MTR, MTHFR, MTRR, BHMT, MAT1A
151843u8932 10.2FPGS, DHFR, SLC19A1, GART, TYMS
16s-adenosylmethionine32 9 18 9 13.2MTRR, BHMT, PCMT1, MTHFR, MTR, MAT2A
17nadph32 18 11.1TXN2, UCP2, XRCC1, MGMT, SPR, DHFR
18purine32 18 11.1GART, SLC19A1, OGG1, DHFR, TFAP2A, TYMS
19dihydrofolate32 10.0TYMS, SHMT1, SPR, FOLR1, FPGS, ATIC
20pteridine32 9.9SPR, SLC19A1, NOS3, NOS1, FPGS, DHFR
21ascorbic acid32 18 10.6OGG1, CGB5, NAT1, CHKA, XRCC1, APEX1
22aicar32 42 9 18 9 13.5NOS2, NOS3, AHCY, DHFR, SLC2A1, TYMS
23thymidylate32 9.4FOLR1, FPGS, ATIC, XRCC1, MTHFD1, MTR
24bleomycin32 9 9 11.3XRCC1, AFP, CGB7, BRCA1, APEX1, CCL2
25methionine32 9.2FOLR1, PON1, FOLR2, MAT2A, MAT1A, GNMT
26aspartate32 9.1FOLH1, APEX1, APOE, ICMT, ALAS2, PRKCA
27choline32 9 18 9 11.7LEPR, BCHE, BHMT, CHKA, MTHFR, IGHE
28methotrexate32 34 42 9 9 12.6GGH, GART, AFP, SLC19A1, CST3, DHFR
29vitamin b1232 8.5AFP, BHMT, MTRR, MTHFR, PON1, CST3
30glutamate32 8.5TYMS, TFAP2A, DNMT1, DHFR, PRKCA, OGG1
315fluorouracil32 8.4FOLH1, MGMT, ERCC2, CCL2, FPGS, XRCC1
32homocysteine32 18 9.0CCL2, MAT1A, APOE, APOB, MGMT, FOLR1
33arginine32 8.0RFC1, XRCC1, BCHE, APOE, LEPR, IGHE
34nitric oxide32 9 18 9 10.9CCL2, APEX1, MGMT, CGB5, MTR, MTRR
35paclitaxel32 34 9 9 10.9TYMS, NAT1, BRCA1, CGB5, FOLR1, MGMT
36superoxide32 18 8.7MTR, LEPR, UCP2, APEX1, CCL2, CBS
37doxorubicin32 34 9 9 10.6DNMT1, ABCC2, NOS3, MGMT, TYMS, BRCA1
38h2o232 7.5TXN2, CBS, APOE, APOB, APEX1, BRCA1
39cysteine32 7.2PAX3, LEPR, MTHFR, MTR, FOLH1, MGMT
40retinoic acid32 42 18 9.1PDGFRA, CYP26A1, CREBBP, NOS1, NOS3, ABCC2
41alanine32 7.0RFC1, BRCA1, ZIC2, BCHE, LEPR, CHKA
42cisplatin32 34 9 9 9.8XRCC1, XRCC3, CGB5, CGB7, MSH3, FOLR1
43glutamine32 6.6IGHE, APOE, APOB, XRCC1, MTR, UCP2
44oxygen32 18 7.6BRCA1, BCHE, LEPR, MTR, CHKA, CGB5
45creatinine32 6.6APOE, CCL2, IGHE, CARM1, CREBBP, NOS1
46cycloheximide32 5.9PAX3, TFAP2A, TYMS, ABCC2, IGHE, NOS2
47folate32 5.2ERCC2, CGB5, SARDH, XRCC3, XRCC1, MTHFS
48estrogen32 4.9BRCA1, EP300, PEMT, APOB, IGHE, CARM1
49serine32 4.9CHKA, MTHFR, MTHFD1, CGB5, FPGS, FOLH1
50vegf32 4.8ERCC2, CREBBP, DNMT1, NOS1, NOS3, CCL2

GO Terms for genes affiliated with Spina Bifida

Sources:
12Gene Ontology
See all sources

Cellular components related to spina bifida according to GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1mitochondrionGO:0057399.2ALAS2, ALDH1L1, TXN2, COQ3, SHMT1, HK1
2cytosolGO:0058297.1GGH, AHCY, HK1, SHMT1, NNMT, NOS3
3nucleusGO:0056344.7NOS3, RNMT, PDGFRA, SHH, SHMT1, NOS2
4cytoplasmGO:0057374.6TYMS, AHCY, SHROOM3, SHMT1, PDGFRA, NOS3

Biological processes related to spina bifida according to GeneDecks:

(show all 36)
idNameGO IDScoreTop Affiliating Genes
1neural tube closureGO:001843INFPRICKLE1, SHROOM3, ALX1, , T, CITED2
2methionine biosynthetic processGO:00908611.0MTHFD1, MTHFR, MTRR, BHMT2, BHMT
3folic acid transportGO:01588410.9SLC19A1, FOLR3, FOLR2, FOLR1
4folic acid metabolic processGO:04665510.9SLC19A1, SHMT1, FOLR1, FPGS, MTHFD1, MTHFR
5sulfur amino acid metabolic processGO:00009610.8AHCY, BHMT, MTR, MAT2A, MAT2B, CBS
6protein methylationGO:00647910.8PRMT1, PRMT2, MTR, BHMT, PCMT1
7tetrahydrofolate interconversionGO:03599910.8MTHFR, MTHFD1, FTCD, SHMT1
8methylationGO:03225910.8AHCY, NNMT, MAT2B, MAT1A, MAT2A, MTR
9S-adenosylhomocysteine metabolic processGO:04649810.8GAMT, PEMT, GNMT, ICMT, PCMT1
10S-adenosylmethionine metabolic processGO:04650010.8GAMT, PEMT, GNMT, PCMT1
11xenobiotic metabolic processGO:00680510.7AHCY, NNMT, CYP26C1, CYP26B1, CYP26A1, MAT2B
12retinoic acid catabolic processGO:03465310.7CYP26C1, CYP26B1, CYP26A1
13S-adenosylmethionine biosynthetic processGO:00655610.7MAT2B, MAT1A, MAT2A
14bone morphogenesisGO:06034910.7TFAP2A, CYP26B1, T, CITED2, PAX1
15one-carbon metabolic processGO:00673010.6MAT2A, MAT1A, MAT2B, ALDH1L1, GNMT, AHCY
16cellular nitrogen compound metabolic processGO:03464110.6GAMT, AHCY, SHMT1, CTH, CBS, AMD1
17folic acid-containing compound biosynthetic processGO:00939610.6MTHFD2, MTHFS, MTHFD1
18homocysteine metabolic processGO:05066710.5MTHFR, MTR, CBS
19vitamin metabolic processGO:00676610.5SLC19A1, SLC2A1, SHMT1, CYP26C1, CYP26B1, CYP26A1
20anterior/posterior pattern specificationGO:00995210.5SHH, CYP26C1, CYP26A1, ALX1, ALDH1A2, VANGL2
21water-soluble vitamin metabolic processGO:00676710.5SLC19A1, SLC2A1, SHMT1, FPGS, MTHFD1, MTHFR
22tetrahydrofolate metabolic processGO:04665310.5MTR, MTHFS, MTHFD2
23liver developmentGO:00188910.3AFP, EP300, ALDH1A2, ICMT, JARID2, CITED2
24pattern specification processGO:00738910.3SHROOM3, SHH, GRHL3, UNCX, ZIC1
25phosphatidylcholine biosynthetic processGO:00665610.2PEMT, ACHE, CHKA, PCYT1A
26negative regulation of hydrolase activityGO:05134610.1NOS3, NOS1, LEPR
27response to drugGO:0424939.8GGH, EP300, PEMT, NNMT, NOS3, TXN2
28nitric oxide biosynthetic processGO:0068099.8SPR, NOS1, NOS2, NOS3
29response to ethanolGO:0454719.4GGH, EP300, PEMT, PRKCA, SHH, NOS3
30arginine catabolic processGO:0065279.2NOS1, NOS2, NOS3
31response to hypoxiaGO:0016668.8EP300, SHH, NOS3, NOS2, NOS1, CREBBP
32DNA repairGO:0062818.8OGG1, TYMS, ERCC2, APEX1, MGMT, MSH3
33positive regulation of transcription from RNA polymerase II promoterGO:0459448.7NRL, CREBBP, NOS1, SHH, TFAP2A, EP300
34small molecule metabolic processGO:0442816.6GAMT, NNMT, NOS3, CREBBP, CTH, SPR
35central nervous system developmentGO:007417INFSHH, CYP26C1, CYP26A1, GRHL3, JARID2,
36establishment of planar polarityGO:001736INFVANGL2, , GRHL3

Molecular functions related to spina bifida according to GeneDecks:

(show all 18)
idNameGO IDScoreTop Affiliating Genes
1folic acid bindingGO:00554210.8MTR, SLC19A1, GNMT, FOLR3, FOLR2, FOLR1
2homocysteine S-methyltransferase activityGO:00889810.8BHMT, BHMT2, MTR
3retinoic acid 4-hydroxylase activityGO:00840110.7CYP26C1, CYP26B1, CYP26A1
4cholinesterase activityGO:00410410.6ACHE, CHKA, BCHE
5histone methyltransferase activityGO:04205410.4PRMT1, PRMT2, CARM1
6DNA (cytosine-5-)-methyltransferase activityGO:00388610.2DNMT1, DNMT3A, TRDMT1
7cobalamin bindingGO:03141910.1TCN2, CUBN, MTR
8tetrahydrobiopterin bindingGO:0346179.8NOS1, NOS2, NOS3
9nitric-oxide synthase activityGO:0045179.8NOS3, NOS2, NOS1
10FMN bindingGO:0101819.8NOS3, NOS2, NOS1, MTRR
11NADP bindingGO:0506619.7NOS3, NOS2, NOS1, SPR, MTRR
12arginine bindingGO:0346189.7NOS3, NOS2, NOS1
13heme bindingGO:0200379.6NOS3, NOS2, NOS1, CYP26C1, CYP26B1, CYP26A1
14iron ion bindingGO:0055069.5MTRR, CYP26A1, CYP26B1, CYP26C1, NOS1, NOS2
15beta-amyloid bindingGO:0015409.5CST3, ACHE, APOE, BCHE
16transcription coactivator activityGO:0037139.1EP300, PRMT2, TFAP2A, ACTL6B, CREBBP, CARM1
17protein homodimerization activityGO:0428038.5SHMT1, ACHE, TFAP2A, PRMT2, PON1, GAMT
18protein bindingGO:005515INFHK1, ACHE, ABCC2, SHH, PDGFRA, RNMT

Sources for Spina Bifida

2CDC
11FMA
18HMDB
19ICD9CM
20KEGG
24MeSH
25MGI
27NCIt
28NDF-RT
31NINDS
32Novoseek
33OMIM
35PubMed
36QIAGEN
43UMLS